Galapagos NV
GLPG
#4563
Rank
$2.11 B
Marketcap
$31.59
Share price
-0.57%
Change (1 day)
17.22%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : $2.87 Billion USD

According to Galapagos NV's latest financial reports the company has $2.87 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$$3.01 B-2.45%
2023-12-31$$3.09 B14.05%
2022-12-31$$2.70 B-9.49%
2021-12-31$$2.99 B-8.86%
2020-12-31$$3.28 B1.96%
2019-12-31$$3.22 B131.91%
2018-12-31$$1.38 B14.4%
2017-12-31$$1.21 B52.15%
2016-12-31$$0.79 B99.97%
2015-12-31$$0.39 B59.19%
2014-12-31$$0.25 B8.62%
2013-12-31$$0.23 B47.32%
2012-12-31$$0.15 B1.92%
2011-12-31$$0.15 B-22.18%
2010-12-31$$0.19 B26.63%
2009-12-31$$0.15 B32.32%
2008-12-31$$0.11 B-18.14%
2007-12-31$$0.14 B-0.37%
2006-12-31$$0.14 B99.58%
2005-12-31$$72.42 M414.99%
2004-12-31$$14.06 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
$45.97 B 1,500.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
$79.27 B 2,660.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$86.29 B 2,905.07%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-$2.6 Billion-190.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
$37.38 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$51.26 B 1,685.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$7.25 B 152.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$21.17 B 637.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
$51.90 B 1,707.52%๐Ÿ‡บ๐Ÿ‡ธ USA